Page 121 - Read Online

Alipov et al. Difference between native and desialylated LDL

O, Pola R, Gaetani E, Magnadottir HB, Wijmenga C, Tromp G, Orekhov AN. Small dense low-density lipoprotein as biomarker for
Ronkainen A, Ruigrok YM, Blankensteijn JD, Mueller T, Wells atherosclerotic diseases. Oxid Med Cell Longev 2017;2017:1273042.
PS, Corral J, Soria JM, Souto JC, Peden JF, Jalilzadeh S, Mayosi 47. Melajärvi N, Gylling H, Miettinen TA. Sialic acids and the metabolism
BM, Keavney B, Strawbridge RJ, Sabater-Lleal M, Gertow K, of low density lipoprotein. J Lipid Res 1996;37:1625-31.
Baldassarre D, Nyyssönen K, Rauramaa R, Smit AJ, Mannarino 48. Lindbohm N, Gylling H, Miettinen TE, Miettinen TA. Sialic
E, Giral P, Tremoli E, de Faire U, Humphries SE, Hamsten A, acid content of LDL and lipoprotein metabolism in combined
Haraldsdottir V, Olafsson I, Magnusson MK, Samani NJ, Levey hyperlipidemia and primary moderate hypercholesterolemia. Clin
AI, Markus HS, Kostulas K, Dichgans M, Berger K, Kuhlenbäumer Chim Acta 1999;285:69-84.
G, Ringelstein EB, Stoll M, Seedorf U, Rothwell PM, Powell JT, 49. Chappey B, Beyssen B, Foos E, Ledru F, Guermonprez JL, Gaux
Kuivaniemi H, Onundarson PT, Valdimarsson E, Matthiasson JC, Myara I. Sialic acid content of LDL in coronary artery disease:
SE, Gudbjartsson DF, Thorgeirsson G, Quyyumi AA, Watkins H, no evidence of desialylation in subjects with coronary stenosis and
Farrall M, Thorsteinsdottir U, Stefansson K. Apolipoprotein(a) increased levels in subjects with extensive atherosclerosis and acute
genetic sequence variants associated with systemic atherosclerosis myocardial infarction: relation between desialylation and in vitro
and coronary atherosclerotic burden but not with venous peroxidation. Arterioscler Thromb Vasc Biol 1998;18:876-83.
thromboembolism. J Am Coll Cardiol 2012;60:722-9. 50. Lindbohm N, Gylling H, Rajaratnam RA, Miettinen TA. Sialic acid
32. Riches K, Porter KE. Lipoprotein(a): cellular effects and molecular content of low-density lipoprotein in women with coronary artery
mechanisms. Cholesterol 2012;2012:923289. disease. J Lab Clin Med 2000;136:110-5.
33. Kwon SW, Lee BK, Hong BK, Kim JY, Choi EY, Sung JM, Rhee 51. Orekhov AN, Ivanova EA, Bobryshev YV. Chapter 2: Naturally
JH, Park YM, Ma DW, Chung H, Mun HS, Lee SJ, Park JK, Min PK, occurring multiple-modified low density lipoprotein. In: Ruiz M,
Yoon YW, Rim SJ, Kwon HM. Prognostic significance of elevated editor. Blood Lipids and Lipoproteins. New York: Nova Science
lipoprotein(a) in coronary artery revascularization patients. Int J Publishers Inc; 2015. p. 13-54.
Cardiol 2013;167:1990-4. 52. Twardowski L, Cheng F, Michaelsen J, Winter S, Hofmann U,
34. Kamstrup PR, Tybjærg-Hansen A, Nordestgaard BG. Extreme Schaeffeler E, Müller S, Sonnenberg M, Steuer K, Ott G, Schwab
lipoprotein(a) levels and improved cardiovascular risk prediction. J M, Franke UF, Torzewski M. Enzymatically modified low-density
Am Coll Cardiol 2013;61:1146-56. lipoprotein is present in all stages of aortic valve sclerosis: implications
35. Gurdasani D, Sjouke B, Tsimikas S, Hovingh GK, Luben RN, for pathogenesis of the disease. J Am Heart Assoc 2015;4:e002156.
Wainwright NW, Pomilla C, Wareham NJ, Khaw KT, Boekholdt SM, 53. Guo S, Sang H, Yang N, Kan Y, Li F, Li Y, Li F, Qin S.
Sandhu MS. Lipoprotein(a) and risk of coronary, cerebrovascular, and Measurement of sialic acid from lipoproteins and human plasma
peripheral artery disease: the EPIC-Norfolk prospective population by liquid chromatography-tandem mass spectrometry. Se Pu
study. Arterioscler Thromb Vasc Biol 2012;32:3058-65. 2014;32:1197-200.
36. Fernández-Higuero JA, Salvador AM, Martín C, Milicua JC, Arrondo 54. Sobenin IA, Galitsyna EV, Grechko AV, Orekhov AN. Small dense
JL. Human LDL structural diversity studied by IR spectroscopy. PLoS and desialylated low density lipoprotein in diabetic patients. Vessel
One 2014;9:e92426. Plus 2017;1:29-37.
37. Segrest JP, Jones MK, De Loof H, Dashti N. Structure of apolipoprotein 55. Zakiev ER, Sukhorukov VN, Melnichenko AA, Sobenin IA, Ivanova
B-100 in low density lipoproteins. J Lipid Res 2001;42:1346-67. EA, Orekhov AN. Lipid composition of circulating multiple-modified
38. Bartlett AL, Stanley KK. All low density lipoprotein particles are low density lipoprotein. Lipids Health Dis 2016;15:134.
partially desialylated in plasma. Atherosclerosis 1998;138:237-45. 56. Trpkovic A, Resanovic I, Stanimirovic J, Radak D, Mousa SA, Cenic-
39. Tertov VV, Orekhov AN, Sobenin IA, Morrisett JD, Gotto AM Milosevic D, Jevremovic D, Isenovic ER. Oxidized low-density
Jr, Guevara JG Jr. Carbohydrate composition of protein and lipid lipoprotein as a biomarker of cardiovascular diseases. Crit Rev Clin
components in sialic acid-rich and -poor low density lipoproteins Lab Sci 2015;52:70-85.
from subjects with and without coronary artery disease. J Lipid Res 57. Gradinaru D, Borsa C, Ionescu C, Prada GI. Oxidized LDL and NO
1993;34:365-75. synthesis--biomarkers of endothelial dysfunction and ageing. Mech
40. Swaminathan N, Aladjem F. The monosaccharide composition and Ageing Dev 2015;151:101-13.
sequence of the carbohydrate moiety of human serum low density 58. Delporte C, Van Antwerpen P, Vanhamme L, Roumeguère T, Zouaoui
lipoproteins. Biochemistry 1976;15:1516-22. Boudjeltia K. Low-density lipoprotein modified by myeloperoxidase
41. Orekhov AN, Tertov VV, Mukhin DN, Mikhailenko IA. Modification in inflammatory pathways and clinical studies. Mediators Inflamm
of low density lipoprotein by desialylation causes lipid accumulation 2013;2013:971579.
in cultured cells: discovery of desialylated lipoprotein with altered 59. Rios FJ, Ferracini M, Pecenin M, Koga MM, Wang Y, Ketelhuth DF,
cellular metabolism in the blood of atherosclerotic patients. Biochem Jancar S. Uptake of oxLDL and IL-10 production by macrophages
Biophys Res Commun 1989;162:206-11. requires PAFR and CD36 recruitment into the same lipid rafts. PLoS
42. Ruelland A, Gallou G, Legras B, Paillard F, Cloarec L. LDL sialic One 2013;8:e76893.
acid content in patients with coronary artery disease. Clin Chim Acta 60. Yang K, Wang X, Liu Z, Lu L, Mao J, Meng H, Wang Y, Hu Y,
1993;221:127-33. Zeng Y, Zhang X, Chen Q, Liu Y, Shen W. Oxidized low-density
43. Lindbohm N. Sialic acid in lipoproteins: with a special reference to lipoprotein promotes macrophage lipid accumulation via the toll-like
low density lipoproteins. Available from: https://helda.helsinki.fi/ receptor 4-Src pathway. Circ J 2015;79:2509-16.
handle/10138/22467. [Last accessed on Sep 6, 2017] 61. Zeya B, Arjuman A, Chandra NC. Lectin-like oxidized low-density
44. Barbosa DS, Maranhão RC, Araújo FB, Chang YH, Hirata MH, lipoprotein (LDL) receptor (LOX-1): a chameleon receptor for
Abdalla DS. Sialic acid and oxidizability of low density lipoprotein oxidized LDL. Biochemistry 2016;55:4437-44.
subfractions of hyperlipidemic patients. Clin Biochem 1995;28:435-41. 62. Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N.
45. Millar JS, Anber V, Shepherd J, Packard CJ. Sialic acid-containing Oxidized low-density lipoprotein. Methods Mol Biol 2010;610:403-17.
components of lipoproteins influence lipoprotein-proteoglycan 63. Oliveira CL, Santos PR, Monteiro AM, Figueiredo Neto AM.
interactions. Atherosclerosis 1999;145:253-60. Effect of oxidation on the structure of human low- and high-density
46. Ivanova EA, Myasoedova VA, Melnichenko AA, Grechko AV, lipoproteins. Biophys J 2014;106:2595-605.
114 Vessel Plus ¦ Volume 1 ¦ September 26, 2017